- Home
- ACNB vs BNTC Comparison
ACNB vs BNTC Comparison
Compare ACNB & BNTC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ACNB
- BNTC
- Stock Information
- Founded
- ACNB 1857
- BNTC 1995
- Country
- ACNB United States
- BNTC United States
- Employees
- ACNB N/A
- BNTC N/A
- Industry
- ACNB Major Banks
- BNTC Biotechnology: Pharmaceutical Preparations
- Sector
- ACNB Finance
- BNTC Health Care
- Exchange
- ACNB Nasdaq
- BNTC Nasdaq
- Market Cap
- ACNB 432.5M
- BNTC 366.6M
- IPO Year
- ACNB N/A
- BNTC N/A
- Fundamental
- Price
- ACNB $43.84
- BNTC $11.97
- Analyst Decision
- ACNB Strong Buy
- BNTC Strong Buy
- Analyst Count
- ACNB 4
- BNTC 6
- Target Price
- ACNB $50.00
- BNTC $23.83
- AVG Volume (30 Days)
- ACNB 37.3K
- BNTC 208.6K
- Earning Date
- ACNB 07-23-2025
- BNTC 05-14-2025
- Dividend Yield
- ACNB 3.16%
- BNTC N/A
- EPS Growth
- ACNB N/A
- BNTC N/A
- EPS
- ACNB 2.79
- BNTC N/A
- Revenue
- ACNB $113,448,000.00
- BNTC N/A
- Revenue This Year
- ACNB $38.67
- BNTC N/A
- Revenue Next Year
- ACNB $5.26
- BNTC N/A
- P/E Ratio
- ACNB $15.43
- BNTC N/A
- Revenue Growth
- ACNB 8.66
- BNTC N/A
- 52 Week Low
- ACNB $32.51
- BNTC $6.91
- 52 Week High
- ACNB $50.72
- BNTC $17.15
- Technical
- Relative Strength Index (RSI)
- ACNB 56.85
- BNTC 29.31
- Support Level
- ACNB $40.71
- BNTC $10.91
- Resistance Level
- ACNB $43.49
- BNTC $12.74
- Average True Range (ATR)
- ACNB 1.02
- BNTC 1.34
- MACD
- ACNB 0.20
- BNTC -0.56
- Stochastic Oscillator
- ACNB 80.54
- BNTC 4.92
About ACNB ACNB Corporation
ACNB Corp provides banking, insurance, and financial services to businesses and consumers, through its wholly-owned subsidiaries, ACNB Bank and ACNB Insurance Services, Inc. The corporation has two reporting segments; the Banking segment which generates the majority of the revenue from banking and wealth management services, including trust and retail brokerage, and ACNB Insurance Services segment which offers a broad range of property and casualty, life and health insurance to both commercial and individual clients.
About BNTC Benitec Biopharma Inc.
Benitec Biopharma Inc is a clinical-stage biotechnology company focused on the advancement of novel genetic medicines. Its technology has the potential to provide a one-shot cure for a wide range of diseases that are addressed by strict ongoing treatment regimens or that have no effective treatment or only palliative care options. The Company is developing a silence and replace-based therapeutic (BB-301) for the treatment of Oculopharyngeal Muscular Dystrophy (OPMD), a chronic, life threatening genetic disorder.